Estimating Influenza Hospitalizations among Children by Grijalva, Carlos G. et al.
Although influenza causes more hospitalizations and
deaths among American children than any other vaccine-
preventable disease, deriving accurate population-based
estimates of disease impact is challenging. Using 2 inde-
pendent surveillance systems, we performed a capture-
recapture analysis to estimate influenza-associated
hospitalizations in children in Davidson County, Tennessee,
during the 2003–2004 influenza season. The New Vaccine
Surveillance Network (NVSN) enrolled children hospital-
ized with respiratory symptoms or fever and tested them for
influenza. The Tennessee Emerging Infections Program
(EIP) identified inpatients with positive influenza diagnostic
test results through review of laboratory and infection con-
trol logs. The hospitalization rate estimated from the cap-
ture-recapture analysis in children <5 years of age was 2.4
per 1,000 (95% confidence interval 1.8–3.8). When NVSN
estimates were compared with capture-recapture esti-
mates, NVSN found 84% of community-acquired cases,
EIP found 64% of cases in which an influenza rapid test
was performed, and the overall sensitivity of NVSN and EIP
for influenza hospitalizations was 73% and 38%, respec-
tively. 
I
nfluenza is an important cause of acute respiratory infec-
tions and hospitalization in children (1–10). Since
influenza may be indistinguishable from other respiratory
and febrile illnesses, identification of infection requires
diagnostic testing. Population-based studies report attack
rates ranging from 15% to 42% in preschool and school
children during typical outbreaks (11,12). However, defin-
ing the impact of influenza for more serious outcomes such
as hospitalizations and deaths requires surveillance and
testing of large populations, which may be expensive and
time-consuming. Influenza surveillance systems can iden-
tify onset of disease activity, characterize viral isolates to
help decide future vaccine composition, assess the impact
of disease in different age and risk groups, and estimate
vaccine impact (4–6,13,14). Identification of all cases of
influenza or an unbiased sample of cases without regard to
vaccination status is necessary to correctly measure dis-
ease impact and to assess vaccine effectiveness.   
From 2003 to 2004, two independent population-based
surveillance systems operated in Davidson County,
Tennessee, to evaluate the impact of influenza disease in
children. One prospectively tested samples from children
<5 years of age who had been hospitalized with fever or
respiratory symptoms. The other retrospectively identified
hospitalizations for children with laboratory-confirmed
influenza based on review of laboratory and infection con-
trol logs. Using data from the 2003–2004 influenza season
independently generated by both systems for Davidson
County residents <5 years of age, we applied a capture-
recapture technique to obtain a better estimate of the total
number of young children hospitalized with influenza. 
Methods
The 2 surveillance systems used in Davidson County to
assess the impact of influenza disease were the New
Vaccine Surveillance Network (NVSN) and the Emerging
Infections Program (EIP). The Centers for Disease Control
and Prevention (CDC) established the NVSN in 1999 to
evaluate the incidence of acute viral respiratory infections
and to assess the impact of new vaccines and vaccination
policies. Influenza surveillance in the NVSN has been con-
ducted among children <5 years of age in the inpatient set-
ting year round since August 2000. Three sites conduct
active population-based surveillance, but only the
Davidson County site was included for this study.
Davidson County has an estimated population of 37,813
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dents <5 years of age hospitalized with respiratory symp-
toms or fever were enrolled 4 days per week and within 48
h of admission after informed consent was obtained. When
a child was enrolled, a questionnaire was administered to
parents, and 1 nasal and 1 throat swab specimen were col-
lected from the child. These specimens were combined in
a tube of veal infusion broth transport medium and deliv-
ered at ambient temperature within 1 to 2 h to the site
research laboratory. Swab specimens are comparable to
nasopharyngeal washes for influenza detection; however,
swabs are more acceptable to families and less expensive
to obtain (15–18). 
Viral culture and reverse transcription–polymerase
chain reaction (RT-PCR) were performed on these samples
and medical charts were reviewed. To exclude nosocomial
infections, NVSN excluded newborns who never left the
hospital and those hospitalized in the previous 4 days.
Similarly, children whose parents refused enrollment and
those who were transferred from another surveillance hos-
pital (to avoid double enrollment) were excluded. Children
who were ill for >14 days did not meet our definition of
acute respiratory illness, and those with fever and neu-
tropenia were excluded because of logistic reasons. Achild
was considered to have influenza if the viral culture was
positive or the RT-PCR result was positive on the initial
test and 1 repeat test using a duplicate specimen aliquot.
The results of these tests were not entered in the hospital
chart and were not communicated to clinicians. NVSN
performed surveillance at 3 hospitals that historically
included at least 95% of all acute respiratory illness hospi-
talizations for children <5 years of age in Davidson County
(14).
EIP, which was also organized and supported by CDC,
was initially designed to estimate the impact of communi-
ty-acquired invasive bacterial and foodborne infections
through a population-based surveillance system (19).
Because of unusual influenza activity during the
2003–2004 influenza season (20), EIP expanded its activi-
ties to conduct active, population-based surveillance for
clinical laboratory-confirmed influenza hospitalizations in
patients <18 years of age. For this analysis, only Davidson
County data for children <5 years of age were included.
EIP estimates the incidence of influenza hospitalizations
by identifying hospitalized children with the diagnosis of
influenza established by clinical laboratory testing. In
Davidson County, in addition to those 3 hospitals where
NVSN conducted surveillance, EIP included 7 additional
hospitals that occasionally admitted Davidson County
children. Hospitalized children <5 years of age with a clin-
ical laboratory test result indicating influenza were identi-
fied and their charts were reviewed. For EIP, whether to
test and which test to use were at the discretion of the
attending physicians who were responsible for the child’s
medical care. Commercially available rapid tests, viral cul-
ture, immunofluorescence antibody staining, RT-PCR,
immunohistochemical staining, and serologic analysis of
paired acute-phase and convalescent-phase sera indicating
a 4-fold increase in influenza antibody titer were the diag-
nostic techniques accepted by the EIP. A statement in the
medical history that the child had a positive rapid test
result for influenza performed in the outpatient setting was
also acceptable. The EIP excluded children who were hos-
pitalized >14 days after they tested positive for influenza
and children whose symptom onset was >3 days after hos-
pital admission.
Achild enrolled as an influenza hospitalization by both
NVSN and EIP was defined as a matched case. The iden-
tification of matched cases was determined retrospectively
by comparing identified cases from the 2 systems and was
based on name, date of birth, and date and place of hospi-
talization. 
Institutional Review Boards (IRBs) of the participating
hospitals and CDC approved NVSN surveillance. Since
EIP influenza surveillance was considered a public health
response program, it was exempt from IRB review and did
not require informed consent of subjects or parents. This
study was reviewed and approved by the Vanderbilt
University IRB. 
Statistical Analysis
We denoted as N the true total number of children <5
years of age hospitalized with influenza during the surveil-
lance period in Davidson County. We estimated N by using
the Petersen capture-recapture estimator (21), which we
denoted  (Figure 1). The first surveillance system
(NVSN) captured n1 cases from the total number of cases
(N). The probability of capture is estimated by n1/N. The
second system (EIP) captured n2 cases, including m2 cases
that were already captured by the first system (recaptured
or matched cases). The probability of being recaptured by
the second system is estimated by m2/n2. When the prob-
abilities of capture by 2 surveillance systems are independ-
ent, the probability of capture by the first system will equal
the probability of recapture by the second. Equating our
estimates of these probabilities and solving for N gives the
Peterson estimator or = n1 × n2/m2. This estimate
assumes that the probability of being captured by 1 system
does not affect the probability of being captured by the
other, that the population is closed (the study population
remained approximately constant and without significant
migration during the study period), and that the ascertain-
ment of influenza by the surveillance systems is valid
(21–25). 
Confidence intervals (CIs) for N were calculated using
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hood-ratio chi-square statistic was <3.84. Since NVSN
attempted to identify all cases on surveillance days, the age
distribution derived from this system likely represented the
true age distribution of cases. This age distribution was
applied to the capture-recapture estimated total cases to
derive age-specific estimates for children <6 months, 6–23
months, and 24–59 months of age.
Data collected in preparing to establish NVSN showed
that admission rates for acute respiratory infections were
similar for study sampling and nonsampling days.
Hospitalizations per 1,000 children for NVSN were esti-
mated by weighting the observed number of enrolled hos-
pitalizations to account for sampling 4 days a week
(Sunday 7:00 a.m. to Thursday 7:00 a.m.) and nonenroll-
ment. This weighting factor has 2 components: sampling
days by week and recruitment rate by age group and quar-
ter of year. The first component is 7 divided by the num-
ber of days per week of enrollment, usually 4. For the
second component, the quarterly enrollment rate for each
of 3 age strata was calculated. The first component was
divided by the second component to give the final weight,
which was multiplied by the age-specific numbers of
enrolled children.
Rates were calculated by dividing the weighted
(NVSN) or unweighted (EIP) number of influenza hospi-
talizations by the population estimates for Davison County
obtained from the 2000 US Census. We assumed that the
population of children <6 months of age was half the num-
ber of children <1 year of age. Sensitivities of each surveil-
lance system were calculated by dividing the rates
generated by each of these systems by the rate generated
through the capture-recapture estimates. Analyses were
performed with Stata version 8.2 software (Stata
Corporation, College Station, TX).
Results
During the 2003–2004 nine-week influenza season in
Davidson County, NVSN identified 274 eligible children
admitted with acute respiratory infections or fever and
enrolled 250 (91%), of whom 29 (11.6%) had influenza.
Nonenrolled children included 18 whose parents were not
available or refused to give consent, 3 who had non-
English–speaking parents and no translator was available,
2 who were discharged before parents could be inter-
viewed, and 1 who was missed. EIP identified 34 cases
meeting its selection criteria through a systematic review
of laboratory and medical records. The total number of
influenza-associated hospitalizations among Davidson
County residents <5 years of age detected by the 2 surveil-
lance systems was 52, 29 for NVSN with surveillance 4
days per week and 34 for EIP with surveillance 7 days per
week. Eleven children were identified in both systems
(matched cases). The capture-recapture analysis estimated
38 cases missed by both systems, yielding 90 (95% CI
67–145) influenza hospitalizations of children <5 years of
age. Among children identified through NVSN, 3% were
admitted to an ICU compared with 6% of children identi-
fied through the EIP system. 
The capture-recapture estimated hospitalization rate
was 2.4 (95% CI 1.8–3.8) per 1,000 children <5 years of
age (Table 1). Children <6 months of age had the highest
hospitalization rate, 9.1 hospitalizations per 1,000 chil-
dren, followed by children 6–23 months of age with 3.0
hospitalizations per 1,000 children. After weighting for
sampling days and nonenrollment, the overall NVSN esti-
mated hospitalization rate for children <5 years of age was
1.7 per 1,000, yielding an overall sensitivity of 73% com-
pared with capture-recapture estimates (Table 2). EIP,
which could only detect a clinical laboratory test with a
positive result for influenza, had an estimated hospitaliza-
tion rate of 0.9 per 1,000 children, yielding a sensitivity of
38% when compared with the capture-recapture estima-
tion. (Figure 2)
Both surveillance systems sought to estimate the total
number of influenza hospitalizations in county residents <5
years of age, but selection criteria differed. Children that
were missed by 1 system and detected by the other were
identified (Table 3). For NVSN, 16 (70%) of 23 missed
case-patients were identified during nonsurveillance days
and therefore not enrolled. In addition, 1 child’s parent
refused enrollment. By design, NVSN rates were adjusted
for missed days of surveillance and nonenrolled cases (14).
However, 6 patients hospitalized on surveillance days were
not included in the NVSN rate estimation. Three of these 6
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Figure 1. Capture-recapture estimation using data from 2 inde-
pendent sources. The first surveillance system (New Vaccine
Surveillance Network [NVSN]) captured n1 cases. The second
system (Emerging Infections Program [EIP]) captured n2 cases,
including m2 cases already captured by NVSN (matched cases).
The Peterson estimator of  N (total cases) is   = n1 × n2/m2. The
Peterson estimate implies that the estimated number of cases
missed by both systems (z) = (b x c)/(a); where b is the number of
enrolled cases by the EIP only, c is the number of enrolled cases
by the NVSN only, and a is the number of matched cases (m2)
(21–25).
ˆ Nchildren had been hospitalized in the previous 4 days and
were not enrolled because they met NVSN exclusion crite-
ria. On admission, 1 child was enrolled and tested negative
for influenza by viral culture and PCR. Exclusion of these
4 cases from the capture-recapture analyses resulted in an
estimated rate of 2.1 per 1,000 community-acquired
influenza hospitalizations, and an NVSN sensitivity of
84%. Two additional children, 1 who had diarrhea and thus
did not meet inclusion criteria, and another who met selec-
tion criteria but was missed, were not enrolled.
For EIP, 12 (67%) of 18 patients identified only through
NVSN were not enrolled because no influenza test had
been ordered by their physician. In addition, 5 patients
were tested with influenza rapid tests but negative results
were obtained. Only 1 child whose chart indicated a posi-
tive influenza rapid test result was not identified by EIP
surveillance. We repeated the capture-recapture analysis
that included only children who had a clinical laboratory
test for influenza. This analysis resulted in an influenza
hospitalization rate of 1.4 per 1,000 children <5 years of
age. The sensitivity of the EIP for detecting influenza was
64% among children who had a rapid test performed.
Influenza viral culture and RT-PCR were performed on
cultures from all children enrolled by NVSN. The diagno-
sis was made by culture alone in 7%, RT-PCR alone in
21%, and by both in 72%. All patients detected by EIP had
a positive result in a commercially available rapid test. The
most common test (59%) was Directigen Flu A + B
(Becton Dickinson Diagnostic Systems, Sparks, MD,
USA), a membrane-based enzyme immunoassay.
Discussion
With fluctuating vaccine supplies, variable onset and
severity of influenza seasons each year, and new recom-
mendations for use of influenza vaccine in children, an
accurate, informative influenza surveillance system is
greatly needed. During the 2003–2004 influenza season,
analysis of data from 2 independent surveillance systems,
both of which included children <5 years of age, provided
better estimates of hospitalization rates since it accounted
for those cases undetected by each system.
NVSN attempted to enroll all potential influenza
admissions on surveillance days and used the most sensi-
tive and specific diagnostic tests to detect influenza (18).
Reliance on viral culture alone for influenza diagnosis
would have missed 21% of NVSN cases, whereas use of
RT-PCR would have missed only 7%. The combination of
these techniques increased the detection of influenza by
the NVSN. In addition, nonsurveillance days and children
whose parents refused enrollment were taken into account
in NVSN rate calculations. With intense surveillance,
NVSN detected 73% of influenza hospitalizations estimat-
ed by the capture-recapture analysis. Exclusion of the 4
possible nosocomial cases increased the sensitivity of
NVSN to 84%. NVSN selection criteria were established
to specifically exclude nosocomial cases, including chil-
dren discharged within 4 days of readmission. One child
was enrolled by NVSN and tested negative for influenza
virus on admission but had a clinical laboratory test result
indicating influenza after >1 week of hospitalization.
Three other children were excluded by NVSN criteria
because of a recent hospitalization. However, with avail-
able information, whether these were nosocomial infec-
tions could not be determined. Based on results of the
capture-recapture analysis, NVSN modified its methodol-
ogy in subsequent years to include children recently hospi-
talized. 
The EIP surveillance system sought to find all hospital-
ized children with positive clinical laboratory test results
for influenza. One limitation of the EIP was that influenza
ascertainment relied on a diagnostic test ordered by the
physician. Another limitation was the sensitivity of the
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ordered or yielded false-negative results, influenza cases
were undetected. EIP surveillance was cheaper and logisti-
cally simpler to implement than NSVN. Since EIP was
considered a public health response program in Tennessee,
it did not require parental informed consent. However, EIP
will underestimate the impact unless combined with addi-
tional information on the proportion of patients with true
cases who are tested and the sensitivity of the diagnostic
tests used. During its first year of influenza surveillance in
Davidson County, EIP missed only 1 patient who could
have potentially been detected. However, because the
rapid influenza antigen test, the only clinical laboratory
influenza test used in these patients, was less sensitive
than RT-PCR plus viral culture, the estimated sensitivity
of EIP for children who actually had clinical laboratory
tests performed was 64%. When compared with viral cul-
ture, these tests have a sensitivity ranging from 44% to
95% and a specificity ranging from 76% to 100% (27–30).
Although the ability of EIP to detect influenza cases was
dependent on these test characteristics, the primary reason
for EIP’s underestimation of rates was that diagnostic tests
for influenza were not ordered for most children admitted
with influenza. The capture-recapture analysis indicated
that only 38% of children <5 years of age hospitalized
with influenza were correctly identified by routine diag-
nostic tests. Thus, not detecting influenza during hospital-
ization resulted not only in underestimating the impact of
influenza, but also in providing limited opportunity for
appropriate antiviral therapy.
Capture-recapture methods emerged as an adaptation of
techniques used by wildlife researchers to obtain better
counts of difficult-to-enumerate wild animals. The simplest
technique uses 2 samples or lists. Using the number of indi-
viduals caught in each sample (captures) and the number of
subjects from the first sample that were captured again by
the second sample (recaptures), one can estimate the num-
ber of subjects not caught in either sample, thus providing
an estimate of the total population size (31–34). The esti-
mation directly accounts for different capture probabilities
of each sample, and allows one to obtain estimates using 1
source that operated 4 days a week (NVSN) and the other
that operated continuously (EIP). 
Since being identified in 1 system did not influence the
possibility of identification in the other system, the inde-
pendence of the 2 systems was assumed. The independ-
ence assumption could have been violated if some factor,
such as severity of influenza illness or viral load, varied
among subjects and the likelihood of detection increased in
both systems with increasing severity or viral load. In this
case, the Peterson method would underestimate the true
population size. In addition, both systems would likely
miss children with very low or no influenza viral loads,
such as those admitted late in the course of illness. This
would also underestimate the true rates.
No significant migration occurred in Davidson County
during the study, and the study population was restricted to
county residents and assumed to be closed. This study was
conducted during a single influenza season and there were
relatively small numbers of cases identified, which pre-
cluded detailed subgroup analyses. However, the final esti-
mation of influenza hospitalization rates was consistent
with previous reports of the 2003–2004 influenza season
and with previous research indicating that children <24
months of age have hospitalization rates similar to those of
persons >65 years of age (11,12,20,35). This estimation
also highlights the great impact of influenza, particularly
in children <6 months of age during a moderately severe
influenza season. Current vaccines are poorly immuno-
genic in this age group and have not been approved for
Estimating Influenza Hospitalizations among Children
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 12, No. 1, January 2006 107
Figure 2. Influenza hospitalization rates in children <5 years of age
by capture-recapture estimates and surveillance systems,
Davidson County, Tennessee, 2003–2004 influenza season.
NVSN, New Vaccine Surveillance Network; EIP, Emerging
Infections Program. these children. Thus, vaccination of household contacts
and out-of-home caregivers of children <6 months of age
is recommended. Additional influenza vaccination of chil-
dren 6–23 months of age has also been recommended to
limit their exposure (35,36). As immunization rates in fam-
ilies of young children increase and routine vaccination for
children 6–23 months of age is implemented, surveillance
systems must be in place to effectively measure the impact
of these preventive strategies.
Combined NVSN and EIP systems analyzed with the
capture-recapture approach appear well suited to this
important task. EIP is a simpler and cheaper system for
identifying children with influenza. Although EIP could
estimate rates more accurately by adjusting for known sen-
sitivities and specificities of clinical diagnostic tests, with-
out information on the frequency of diagnostic testing, it
would be impossible to determine and adjust for the pro-
portion of influenza this system captures. Thus, the degree
of underascertainment would be unknown. In addition,
such diagnostic testing will likely change over time, mak-
ing year-to-year comparisons of disease impact difficult.
NVSN attempted to estimate the true impact of influenza
hospitalizations by testing all children with specific admis-
sion criteria, adjusting for nonenrollment and nonsurveil-
lance days, and providing an unbiased sample of
influenza-positive children for further analyses such as
vaccine effectiveness estimates. However, this system also
underestimated the total influenza impact. The combined
systems gave the best estimate of disease impact.
Currently, no population-based surveillance systems
are available to monitor the influenza vaccine program in
adults. Using a combination of 2 systems similar to NVSN
and EIP could be a model for surveillance of influenza in
adults. The more expensive and labor-intensive NVSN-
type surveillance could be conducted at representative hos-
pitals in a geographic area for limited periods during the
influenza season (e.g., 1 day/week at each hospital). The
EIP-type surveillance system could attempt to identify all
persons admitted with influenza identified through routine
testing. Capture-recapture methods could be used to more
accurately estimate serious influenza impact. Comparison
of patients could determine whether those identified
through cheaper EIP methods were representative of all
patients with respect to important characteristics such as
influenza vaccination status and severity of disease.
Capture-recapture techniques should be considered as
methods to best use limited resources for essential surveil-
lance activities.
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The goal of the conference is to enhance prevention and control of infectious diseases among women 
worldwide, ensuring that these efforts address global inequalities. 
• Diseases disproportionately affecting women across the life span
• Diseases occurring in populations but having distinct impact on women 
• Diseases affecting pregnancy, birth, and infants
• Gender-specific interventions against infections in diverse populations of women
• Information-sharing of infectious disease science
• Collaboration between individuals and organizations around the globe
• Increased role for women in basic and applied science careers
More information is available at www.womenshealthconf.org; email omwh@cdc.gov or call 1-404-371-5308.